Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiotherapy Combined With Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer (CREATE): A Open-label, Single-arm, Phase II Study

NCT05162196 is registered in ClinicalTrials.gov with Wuhan University as lead sponsor.

NCT NCT05162196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05162196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiotherapy Combined With Niraparib and Toripalimab in Patients With Recurrent Small Cell Lung Cancer (CREATE): A Open-label, Single-arm, Phase II Study
Lead sponsor
Wuhan University
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2022
Completion date
December 31, 2024
Enrollment
57 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent small cell lung cancer